StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

Addex Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.06 CHF, down 185.7% from the year before. The highest annual figure on record is 0.07 CHF in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-0.06 CHF-185.7%
FY2024Dec 31, 20240.07 CHF–
FY2023Dec 31, 2023-0.14 CHF–
FY2022Dec 31, 2022-0.46 CHF–
FY2021Dec 31, 2021-0.45 CHF–
FY2020Dec 31, 2020-0.48 CHF–
FY2019Dec 31, 2019-0.56 CHF–
FY2018Dec 31, 2018-0.07 CHF–
FY2017Dec 31, 2017-0.25 CHF–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-0.01 CHF–
Q2 FY2025Jun 30, 2025-0.02 CHF–
Q2 FY2024Jun 30, 20240.13 CHF–
Q2 FY2023Jun 30, 2023-0.04 CHF–
Q2 FY2022Jun 30, 2022-0.19 CHF–
Q2 FY2021Jun 30, 2021-0.14 CHF–

More Addex Therapeutics figures

See a number that looks wrong?